SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-055365
Filing Date
2018-10-25
Accepted
2018-10-25 16:45:28
Documents
7
Period of Report
2018-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tv505364_8k.htm 8-K 17122
2 EXHIBIT 10.1 tv505364_ex10-1.htm EX-10.1 351867
3 GRAPHIC tv505364_ex10-1img1.jpg GRAPHIC 146265
4 GRAPHIC tv505364_ex10-1img2.jpg GRAPHIC 111904
5 GRAPHIC tv505364_ex10-1img3.jpg GRAPHIC 270681
6 GRAPHIC tv505364_ex10-1img4.jpg GRAPHIC 101887
7 GRAPHIC tv505364_ex10-1img5.jpg GRAPHIC 135483
  Complete submission text file 0001144204-18-055365.txt   1426508
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 181139415
SIC: 2836 Biological Products, (No Diagnostic Substances)